Related by context. Frequent words. (Click for all words.) 72 xenograft models 63 hematologic malignancies 62 Azedra 61 hematologic cancers 60 chemotherapeutics 60 hematological cancers 60 antitumor activity 59 orally bioavailable 59 GRN#L 59 hematological malignancies 59 HGS ETR1 59 #ME# 58 hypoxia inducible factor 58 immunomodulator 58 potent inhibitor 58 investigational compounds 58 chemotherapeutic agents 58 preclinical models 58 chemotherapeutic agent 57 Hsp# inhibitors 57 kinase inhibitor 57 cytotoxic agents 57 RGB # 57 chemotherapeutic drugs 57 immunomodulatory 57 solid tumors 57 EpCAM 57 anticancer agent 57 induces apoptosis 57 organ transplant rejection 57 selective inhibitor 56 humanized monoclonal antibody 56 gastric cancers 56 etoposide 56 Perifosine 56 androgen independent 56 IMC A# 56 antitumor 56 neoplasm 56 anticancer agents 56 cytotoxic 56 HER2 positive metastatic breast 56 IGF 1R 56 cytotoxicity 55 glioblastoma multiforme GBM 55 INGN 55 CA4P 55 pharmacodynamics 55 chemotherapeutic 55 EGFR inhibitors 55 tyrosine kinase inhibitor 55 CYC# 55 systemic lupus erythematosus SLE 55 VEGFR2 55 SCH # 55 DAVANAT 55 malignancies 55 resistant ovarian cancer 55 Irinotecan 55 axitinib 54 oncology indications 54 induce apoptosis 54 Voreloxin 54 Preclinical studies 54 PXD# 54 tyrosine kinase inhibitors 54 angiogenesis inhibitor 54 humanized anti 54 anticancer therapy 54 neoplasms 54 lung prostate 54 tesetaxel 53 prostate breast 53 colon lung 53 hepatocellular carcinoma HCC 53 therapeutic regimens 53 NNRTIs 53 EGFR mutations 53 OXi# 53 metastatic cancers 53 BiTE antibody 53 carcinomas 53 breast ovarian 52 chronic lymphocytic leukemia CLL 52 dosing regimens 52 tumor vasculature 52 virologic 52 ALN VSP 52 relapsed refractory 52 tumor antigens 52 secondary hyperparathyroidism 52 talabostat 52 Azixa 52 tanespimycin 52 metastatic renal cell carcinoma 52 dose cohorts 52 relapsed refractory multiple myeloma 52 targeted kinase inhibitor 52 recurrent ovarian cancer 52 dose regimens 52 Neuradiab